Acura Pharmaceuticals Inc. (ACUR) |
|
0.322 -0.026 (-7.47%)
|
07-02 15:33 |
|
Open: |
0.28 |
Pre. Close: |
0.348 |
|
High:
|
0.35 |
Low:
|
0.28 |
|
Volume:
|
3,645 |
Market Cap:
|
7M |
|
|
|
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.35 - 0.353 |
0.353 - 0.355 |
|
Low:
|
0.275 - 0.278 |
0.278 - 0.279 |
|
Close:
|
0.316 - 0.321 |
0.321 - 0.324 |
|
Technical analysis |
as of: 2020-07-02 4:27:10 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 0.41 One year: 0.46 |
| Support: |
Support1: 0.28 Support2: 0.23 |
| Resistance: |
Resistance1: 0.35 Resistance2: 0.39 |
| Pivot: |
0.32 |
| Moving Average: |
MA(5): 0.34 MA(20): 0.32 
MA(100): 0.31 MA(250): 0.31 |
| MACD: |
MACD(12,26): Signal(9): |
| Stochastic oscillator: |
%K(14,3): 85.71 %D(3): 90.16 |
| RSI: |
RSI(14): 49.42 |
| 52-week: |
High: 0.63 Low: 0.12 Change(%): 40.0 |
| Average Vol(K): |
3-Month: 1303 10-Days: 654 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.ACUR has closed above bottom band by 49.1%. Bollinger Bands are 37.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Tue, 30 Jun 2020
ACURA PHARMACEUTICALS, INC. (NASDAQ:ACUR) Files An 8-K Results of Operations and Financial Condition - Market Exclusive
Mon, 29 Jun 2020
Acura Pharmaceuticals Announces First Quarter 2020 Financial Results Other OTC:ACUR - GlobeNewswire
Mon, 23 Mar 2020
Acura Pharmaceuticals Provides an Update on the Development of LTX-03 - GlobeNewswire
Fri, 28 Feb 2020
Acura Pharmaceuticals Announces Third Quarter 2019 Financial Results Other OTC:ACUR - GlobeNewswire
Mon, 10 Feb 2020
Acura Pharmaceuticals Announces Second Quarter 2019 Financial Results Other OTC:ACUR - GlobeNewswire
Thu, 19 Dec 2019
ACUR | Acura Pharmaceuticals Inc. Stock Price & News - WSJ - Wall Street Journal
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
|
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: |
| Sector: |
| Industry: |
| Shares Out. (M) |
22 |
| Shares Float (M) |
7 |
|
% Held by Insiders
|
52.81 |
|
% Held by Institutions
|
9.05 |
|
Shares Short (K)
|
90 |
|
Shares Short P. Month (K)
|
76 |
Stock Financials |
|
EPS
|
-0.141 |
|
EPS Est This Year
|
-0.460 |
|
EPS Est Next Year
|
0.370 |
|
Book Value (p.s.)
|
-0.220 |
|
Profit Margin
|
-142.04 |
|
Operating Margin
|
-27.29 |
|
Return on Assets (ttm)
|
-19.2 |
|
Return on Equity (ttm)
|
|
|
Qtrly Rev. Growth
|
1836.5 |
|
Gross Profit (p.s.)
|
0.053 |
|
Sales Per Share
|
0.123 |
|
EBITDA (p.s.)
|
-0.021 |
|
Qtrly Earnings Growth
|
1837.50 |
|
Operating Cash Flow (M)
|
-1 |
|
Levered Free Cash Flow (M)
|
-1 |
Stock Valuations |
|
PE Ratio
|
-2.28 |
|
PEG Ratio
|
|
|
Price to Book value
|
-1.46 |
|
Price to Sales
|
2.62 |
|
Price to Cash Flow
|
-11.28 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
